Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105390584 | 10539058 | 4 | F | 2013 | 20160926 | 20141023 | 20160929 | EXP | US-GLAXOSMITHKLINE-A0815423A | GLAXOSMITHKLINE | 0.00 | F | Y | 72.11000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105390584 | 10539058 | 1 | PS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | 1 PUFF(S), BID | D | 21077 | 1 | DF | INHALATION POWDER | BID | ||||||
| 105390584 | 10539058 | 2 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | D | 21077 | INHALATION POWDER | ||||||||||
| 105390584 | 10539058 | 3 | SS | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | D | 21077 | INHALATION POWDER | ||||||||||
| 105390584 | 10539058 | 4 | SS | COREG CR | CARVEDILOL PHOSPHATE | 1 | 20 MG, UNK | D | 0 | 20 | MG | PROLONGED-RELEASE CAPSULE | |||||||
| 105390584 | 10539058 | 5 | SS | COREG CR | CARVEDILOL PHOSPHATE | 1 | D | 0 | PROLONGED-RELEASE CAPSULE | ||||||||||
| 105390584 | 10539058 | 6 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | U | 0 | |||||||||||
| 105390584 | 10539058 | 7 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | U | 0 | |||||||||||
| 105390584 | 10539058 | 8 | C | XANAX | ALPRAZOLAM | 1 | U | 0 | |||||||||||
| 105390584 | 10539058 | 9 | C | ASPIRIN +ASCORBIC ACID +CAFFEINE +MENTHOL | 2 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105390584 | 10539058 | 1 | Lung disorder |
| 105390584 | 10539058 | 2 | Pericardial effusion |
| 105390584 | 10539058 | 3 | Chronic obstructive pulmonary disease |
| 105390584 | 10539058 | 4 | Lung disorder |
| 105390584 | 10539058 | 5 | Pericardial effusion |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105390584 | 10539058 | OT |
| 105390584 | 10539058 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105390584 | 10539058 | Aortic occlusion | |
| 105390584 | 10539058 | Arterial disorder | |
| 105390584 | 10539058 | Cardiac failure congestive | |
| 105390584 | 10539058 | Cholecystectomy | |
| 105390584 | 10539058 | Dyspnoea | |
| 105390584 | 10539058 | Hospice care | |
| 105390584 | 10539058 | Renal disorder | |
| 105390584 | 10539058 | Renal failure | |
| 105390584 | 10539058 | Stent placement |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105390584 | 10539058 | 1 | 2007 | 0 | ||
| 105390584 | 10539058 | 4 | 2007 | 0 |